COMPLETE DIGEORGE ANOMALY

Complete DiGeorge Anomaly (cDGA) is a rare disease affecting approximately 1 in 300,000 infants. Children with complete DiGeorge Anomaly are born without a thymus gland, resulting in primary immunodeficiency. The disease is almost uniformly fatal within the first 24 months of life if untreated.

For more information about Enzyvant’s commitment to complete DiGeorge Anomaly, please contact the Enzyvant team at medinfo@enzyvant.com.

For more information on RVT-802, an investigational thymic-tissue based therapy for the treatment of primary immunodeficiency resulting from congenital athymia associated with complete DiGeorge Anomaly CLICK HERE

For more information about complete DiGeorge Anomaly.

For more information about complete DiGeorge Anomaly.